Together with BAF47, SS18 regulates normal expression patterns from enhancers and promoters; however malignant gene translocation (SS18-SSX) in synovial sarcoma evicts BAF47 from the complex and new fusion oncoprotein activates bivalent genes [77]. The gene discussed is SMARCB1; the disease is synovial sarcoma.